ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 106 filers reported holding ATHIRA PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,020 | -77.5% | 1,000 | -67.2% | 0.00% | – |
| Q2 2023 | $8,989 | +69.1% | 3,047 | +43.3% | 0.00% | – |
| Q1 2023 | $5,316 | -75.4% | 2,126 | -68.8% | 0.00% | – |
| Q4 2022 | $21,581 | +7.9% | 6,808 | +2.6% | 0.00% | – |
| Q3 2022 | $20,000 | +1900.0% | 6,637 | +1835.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 343 | +363.5% | 0.00% | – |
| Q1 2022 | $1,000 | – | 74 | +7300.0% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 1 | -100.0% | 0.00% | -100.0% |
| Q3 2020 | $10,327,000 | – | 559,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,691,623 | $57,938,000 | 8.52% |
| ACUTA CAPITAL PARTNERS, LLC | 393,000 | $13,460,000 | 3.66% |
| Logos Global Management LP | 947,873 | $32,465,000 | 2.78% |
| RTW INVESTMENTS, LP | 2,685,779 | $88,899,000 | 1.49% |
| Avidity Partners Management LP | 1,043,873 | $35,753,000 | 1.16% |
| Perceptive Advisors | 3,114,805 | $106,682,000 | 1.14% |
| Sofinnova Investments, Inc. | 509,168 | $17,439,000 | 1.04% |
| HighVista Strategies LLC | 32,062 | $1,098,000 | 0.70% |
| Rock Springs Capital Management LP | 860,902 | $29,486,000 | 0.62% |
| PFM Health Sciences, LP | 470,227 | $16,105,000 | 0.57% |